Article Information
PubMed
History
- Accepted May 8, 2017
- Published online June 18, 2017.
Copyright & Usage
© 2017 Joule Inc. or its licensors
Author Information
- May S. ElSherif, MD MPH,
- Catherine Brown, BN RN,
- Donna MacKinnon-Cameron, MMath,
- Li Li, MSc,
- Trina Racine, PhD,
- Judie Alimonti, PhD,
- Thomas L. Rudge, PhD,
- Carol Sabourin, PhD,
- Peter Silvera, PhD,
- Jay W. Hooper, PhD,
- Steven A. Kwilas, PhD,
- Nicole Kilgore, MS,
- Christopher Badorrek, PhD,
- W. Jay Ramsey, MD PhD,
- D. Gray Heppner, MD,
- Tracy Kemp, MPH,
- Thomas P. Monath, MD,
- Teresa Nowak, BS,
- Shelly A. McNeil, MD,
- Joanne M. Langley, MD MSc,
- Scott A. Halperin, MD⇑
- on behalf of the Canadian Immunization Research Network
- Canadian Center for Vaccinology (ElSherif, Brown, MacKinnon-Cameron, Li, McNeil, Langley, Halperin), IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS; National Microbiology Laboratory (Racine, Alimonti), Winnipeg, Man.; Battelle Biomedical Research Center (Rudge, Sabourin), Columbus, Ohio; United States Army Medical Research Institute of Infectious Disease (Silvera, Hooper, Kwilas), Fort Detrick, Md.; Joint Program Executive Office for Chemical and Biological Defense Medical Countermeasure Systems’ Joint Vaccine Acquisition Program (Kilgore, Badorrek), Fort Detrick, Md.; BioProtection Systems/NewLink Genetics Corporation (Ramsey, Heppner, Kemp, Monath), Ames, Iowa; Veristat LLC (Nowak), Southborough, Mass.
- Correspondence to: Scott Halperin, scott.halperin{at}dal.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
Podcast